Reactivation of Graves' orbitopathy after rehabilitative orbital decompression. 2007

Lelio Baldeschi, and Antonella Lupetti, and Phung Vu, and Iris M M J Wakelkamp, and Mark F Prummel, and Wilmar M Wiersinga
Orbital Center, Department of Ophthalmology, University of Amsterdam, Amsterdam, The Netherlands. l.baldeschi@amc.uva.nl

OBJECTIVE To present and discuss three cases of apparent reactivation of Graves' orbitopathy (GO) after orbital decompression and to evaluate the incidence of this phenomenon. METHODS Observational case series and retrospective follow-up study. METHODS A few weeks after surgery 2 patients with GO (patients 1 and 2), treated at our institution with rehabilitative bony orbital decompression during the static phase of the disease showed clinical and radiologic evidence of reactivated orbitopathy. After this observation, a sample of 249 patients who had consecutively undergone the same treatment for the same reason before the second of the 2 observed patients was selected for this study. METHODS The records of the selected patients were retrospectively reviewed searching for cases presenting with clinical and radiologic evidence of GO reactivated as a consequence of any type of bony orbital decompression. Patients treated with perioperative systemic glucocorticoids or who had concurrent periorbital diseases, injuries, or surgeries, or who had immunocompromised conditions or a follow-up of < or =2 months, were excluded. METHODS Incidence of reactivation. Clinical history, clinical and radiologic characteristics, treatment modalities, and time course of the reactivation in patients presenting with this phenomenon. RESULTS Decompression surgery took place between 1994 and 2000. Eleven patients were excluded for having been treated with perioperative glucocorticoids. Only 1 patient (patient 3) presented with reactivation. The incidence of the phenomenon that we regard as reactivation of GO after rehabilitative bony orbital decompression was therefore 1.3% (3/239). In all 3 patients, the reactivation took place a few weeks after surgery, after an early normal convalescence period and could be controlled with systemic immunosuppression or orbital radiotherapy. None of the patients we report developed further episodes of reactivation during the follow-up period (mean, 7.5 years). CONCLUSIONS Based on its clinical characteristics, we suggest naming our observation delayed decompression-related reactivation and we propose using its acronym DDRR when referring to it. Although DDRR appears to be a rare event, it is important for physicians and patients to be aware of its possible occurrence with rehabilitative decompression surgery.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D008775 Methylprednisolone A PREDNISOLONE derivative with similar anti-inflammatory action. 6-Methylprednisolone,Medrol,Metipred,Urbason,6 Methylprednisolone
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009915 Orbit Bony cavity that holds the eyeball and its associated tissues and appendages. Eye Socket,Eye Sockets,Orbits,Socket, Eye,Sockets, Eye
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D011878 Radiotherapy The use of IONIZING RADIATION to treat malignant NEOPLASMS and some benign conditions. Radiotherapy, Targeted,Targeted Radiotherapy,Radiation Therapy,Radiation Therapy, Targeted,Radiation Treatment,Targeted Radiation Therapy,Radiation Therapies,Radiation Therapies, Targeted,Radiation Treatments,Radiotherapies,Radiotherapies, Targeted,Targeted Radiation Therapies,Targeted Radiotherapies,Therapies, Radiation,Therapies, Targeted Radiation,Therapy, Radiation,Therapy, Targeted Radiation,Treatment, Radiation
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D012086 Reoperation A repeat operation for the same condition in the same patient due to disease progression or recurrence, or as followup to failed previous surgery. Revision, Joint,Revision, Surgical,Surgery, Repeat,Surgical Revision,Repeat Surgery,Revision Surgery,Joint Revision,Revision Surgeries,Surgery, Revision
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

Lelio Baldeschi, and Antonella Lupetti, and Phung Vu, and Iris M M J Wakelkamp, and Mark F Prummel, and Wilmar M Wiersinga
February 2024, American journal of ophthalmology,
Lelio Baldeschi, and Antonella Lupetti, and Phung Vu, and Iris M M J Wakelkamp, and Mark F Prummel, and Wilmar M Wiersinga
September 2018, Journal of endocrinological investigation,
Lelio Baldeschi, and Antonella Lupetti, and Phung Vu, and Iris M M J Wakelkamp, and Mark F Prummel, and Wilmar M Wiersinga
January 2012, Medicinski pregled,
Lelio Baldeschi, and Antonella Lupetti, and Phung Vu, and Iris M M J Wakelkamp, and Mark F Prummel, and Wilmar M Wiersinga
March 2013, Indian journal of endocrinology and metabolism,
Lelio Baldeschi, and Antonella Lupetti, and Phung Vu, and Iris M M J Wakelkamp, and Mark F Prummel, and Wilmar M Wiersinga
March 2012, Eye (London, England),
Lelio Baldeschi, and Antonella Lupetti, and Phung Vu, and Iris M M J Wakelkamp, and Mark F Prummel, and Wilmar M Wiersinga
May 1993, Ophthalmology,
Lelio Baldeschi, and Antonella Lupetti, and Phung Vu, and Iris M M J Wakelkamp, and Mark F Prummel, and Wilmar M Wiersinga
January 2010, International journal of oral and maxillofacial surgery,
Lelio Baldeschi, and Antonella Lupetti, and Phung Vu, and Iris M M J Wakelkamp, and Mark F Prummel, and Wilmar M Wiersinga
January 2022, Ophthalmic plastic and reconstructive surgery,
Lelio Baldeschi, and Antonella Lupetti, and Phung Vu, and Iris M M J Wakelkamp, and Mark F Prummel, and Wilmar M Wiersinga
June 2008, Clinical ophthalmology (Auckland, N.Z.),
Lelio Baldeschi, and Antonella Lupetti, and Phung Vu, and Iris M M J Wakelkamp, and Mark F Prummel, and Wilmar M Wiersinga
April 2017, Eye (London, England),
Copied contents to your clipboard!